Safety and Pharmacokinetics of Orally Administered Gallium Maltolate in Various Refractory Malignancies

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00050687
Recruitment Status : Terminated
First Posted : December 19, 2002
Last Update Posted : January 28, 2011
Information provided by:
Titan Pharmaceuticals

No Study Results Posted on for this Study
  Recruitment Status : Terminated
  Actual Primary Completion Date : March 2005
  Actual Study Completion Date : March 2005
  Certification/Extension First Submitted : January 11, 2011